Medicare AdvantageReimbursementMedium impact
MA09.009w, Reimbursement for Radiopharmaceutical Agents for Professional Providers
Independence Blue Cross·Nuclear Medicine, Radiology, Oncology +1 more·Claims & Billing
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated their reimbursement policy for radiopharmaceutical agents used by professional providers. This policy change affects how radiopharmaceuticals are covered and reimbursed, requiring billing teams to review and adjust their procedures for these specialized medications.
Action Required
By January 1, 2025: Billing team must review the complete MA09.009w policy document at the source URL to understand specific reimbursement changes for radiopharmaceutical agents. Update billing procedures and fee schedules accordingly for Medicare Advantage plans. Verify current radiopharmaceutical billing practices align with new requirements.